NCT06000423 Tranexamic Acid to Reduce Contraceptive-related Bleeding Side Effects Status COMPLETED Phase PHASE4
NCT05997914 Storytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial Fibrillation Status ENROLLING_BY_INVITATION Phase NA
NCT05987787 Suture Reinforcement to Reduce the Leak Rate After Sleeve Gastrectomy Status COMPLETED Phase N/A
NCT05986942 Evaluation of the Postoperative Agitation Prevention and Analgesic Efficacy of Perioperative Dexmedetomidine Infusion in a Pediatric Patient Group to Undergo Tonsillectomy and Adenoidectomy Status COMPLETED Phase N/A
NCT05874674 The Safety of Nafamostat Mesylate for Patients With High Risk Bleeding Undergoing Hemodialysis: A Pilot Study Status RECRUITING Phase NA
NCT05817656 Colonoscopic Sucralfate Spray in Prevention of Delayed Polypectomy Bleeding Status UNKNOWN Phase PHASE1
NCT05780125 Effectiveness of Different Fibrinogen Preparations in Restoring Clot Firmness Status COMPLETED Phase PHASE2
NCT05764356 Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study II Status NOT_YET_RECRUITING Phase N/A
NCT05734937 Ultrasound Evaluation of Gastric Volume in Pediatric Patients Undergoing Adenotonsillectomy Surgery Status COMPLETED Phase NA
NCT05711524 Transfusion of Pathogen Reduced Cryoprecipitated Fibrinogen to Expedite Product Availability in Perioperative Bleeding Status COMPLETED Phase PHASE4
NCT05672420 Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies Status UNKNOWN Phase PHASE1/PHASE2
NCT05669313 The Effects of Hypothermia and Acidosis on Coagulation During Treatment With Rivaroxaban Measured With ROTEM Status COMPLETED Phase N/A
NCT05563883 Atrial Fibrillation and Cancer: a Nationwide French Cohort Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05542277 A Pre-market, Multi-center, International, Double-blind, Randomized, Two-arms, Controlled, Prospective Clinical Investigation Assessing the Safety and Performance of a Medical Device (ClearPlasma™) for the Treatment of Patients Undergoing Coronary Artery Bypass or Valve Replacement Status TERMINATED Phase NA
NCT05505591 Intravenous CAngrelor in High-bleeding Risk Patients Undergoing percutaneouS Coronary Intervention (ICARUS) Registry Status UNKNOWN Phase N/A